Moreover, a few studies have also shown that in cancer, PIK3CA and PTEN mutations are not necessarily mutually exclusive but that their concomitant alterations can have biological effects and therapeutic implication [59,60,61]. This evidence concerns the gene PIK3CA and cancer.